Cambridge Nutritional Sciences
plc
(the "Company" or "CNSL")
Directorate Change
Cambridge Nutritional Sciences plc
(AIM:CNSL), the specialist medical diagnostics company focused on
industry-leading Health and Nutrition products, announces that
James Cooper, currently Chief Operating Officer, has been appointed
as interim Chief Executive Officer of CNSL with immediate
effect. After two years as CEO, and thirteen years with the
Company, Jag Grewal has tendered his resignation and stepped down
from the Board with immediate effect.
Jag will continue to work with the
Board to effect an orderly handover.
In his brief tenure as COO, James has
demonstrated a wide range of operational and management skills and
the Board is confident he will be a very capable interim
CEO.
Cally Rand, Chair of CNSL , said:
"Jag has been an integral part of the business over the last
thirteen years and has managed the business extremely well as CNSL
has transitioned away from infectious disease
diagnostics. I would also like to extend
my sincere thanks to Jag for the huge role he has played in the
foundation and development of this Company. On behalf of the entire
Board, we wish him the best for the future"
Jag Grewal
commented:
"I
have deeply enjoyed leading CNS plc and working alongside such a
dedicated and talented team and supportive Board. I want to
express my deepest gratitude to the Board, our leadership team, and
all of our employees for their support, collaboration and hard work
during my tenure. I am confident that the Company is in a
strong position to continue its trajectory of growth and
success."
Contacts:
|
Cambridge Nutritional Sciences
PLC
|
www.cnsplc.com
|
|
Cally Rand Executive Chair
|
|
|
|
|
|
Cavendish Capital Markets Limited
|
Tel: 020
7220 0500
|
|
Geoff Nash / Edward Whiley /
(Corporate Finance)
|
|
|
Nigel Birks / Harriet Ward
(ECM)
|
|
|
|
|
|
|
|
|
|
| |
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc
(AIM: CNSL) is a specialist medical diagnostics company focused on
industry-leading Health and Nutrition products.
The information contained within
this announcement is deemed by the Company to constitute inside
information as stipulated under the Market Abuse Regulations (EU)
No. 596/2014 (MAR) as in force in the United Kingdom pursuant to
the European Union (Withdrawal) Act 2018. Upon the publication of
this announcement via Regulatory Information Service (RIS), this
inside information is now considered to be in the public
domain.
